Teladoc Health (TDOC) Competitors

$6.58 +0.02 (+0.23%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$6.54 -0.05 (-0.76%)

As of 05/22/2026 07:59 PM Eastern

TDOC vs. AMZN, CRSP, ROKU, ZM, and AMWL

Should you buy Teladoc Health stock or one of its competitors? MarketBeat compares Teladoc Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Teladoc Health include Amazon.com (AMZN), CRISPR Therapeutics (CRSP), Roku (ROKU), Zoom Communications (ZM), and American Well (AMWL).

How does Teladoc Health compare to Amazon.com?

Teladoc Health (NYSE:TDOC) and Amazon.com (NASDAQ:AMZN) are related companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

Amazon.com has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Amazon.com, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53B	0.47	-$200.32M	-$0.97	N/A
Amazon.com	$716.92B	4.00	$77.67B	$8.36	31.86

Teladoc Health currently has a consensus target price of $7.53, suggesting a potential upside of 14.37%. Amazon.com has a consensus target price of $312.66, suggesting a potential upside of 17.40%. Given Amazon.com's stronger consensus rating and higher possible upside, analysts clearly believe Amazon.com is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.22
Amazon.com	0 Sell rating(s)	3 Hold rating(s)	57 Buy rating(s)	0 Strong Buy rating(s)	2.95

In the previous week, Amazon.com had 229 more articles in the media than Teladoc Health. MarketBeat recorded 237 mentions for Amazon.com and 8 mentions for Teladoc Health. Amazon.com's average media sentiment score of 0.91 beat Teladoc Health's score of 0.89 indicating that Amazon.com is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	5 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Amazon.com	148 Very Positive mention(s)	41 Positive mention(s)	24 Neutral mention(s)	11 Negative mention(s)	11 Very Negative mention(s)	Positive

Teladoc Health has a beta of 2.08, suggesting that its share price is 108% more volatile than the broader market. Comparatively, Amazon.com has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market.

Amazon.com has a net margin of 12.22% compared to Teladoc Health's net margin of -6.81%. Amazon.com's return on equity of 19.92% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-6.81%	-11.45%	-5.54%
Amazon.com	12.22%	19.92%	9.86%

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 72.2% of Amazon.com shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by insiders. Comparatively, 8.9% of Amazon.com shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Amazon.com beats Teladoc Health on 14 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to CRISPR Therapeutics?

CRISPR Therapeutics (NASDAQ:CRSP) and Teladoc Health (NYSE:TDOC) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

Teladoc Health has a net margin of -6.81% compared to CRISPR Therapeutics' net margin of -13,856.54%. Teladoc Health's return on equity of -11.45% beat CRISPR Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CRISPR Therapeutics	-13,856.54%	-25.66%	-20.39%
Teladoc Health	-6.81%	-11.45%	-5.54%

Teladoc Health has higher revenue and earnings than CRISPR Therapeutics. CRISPR Therapeutics is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CRISPR Therapeutics	$3.51M	1,383.82	-$581.60M	-$6.22	N/A
Teladoc Health	$2.53B	0.47	-$200.32M	-$0.97	N/A

CRISPR Therapeutics has a beta of 1.74, indicating that its stock price is 74% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.08, indicating that its stock price is 108% more volatile than the broader market.

CRISPR Therapeutics presently has a consensus target price of $65.47, indicating a potential upside of 30.01%. Teladoc Health has a consensus target price of $7.53, indicating a potential upside of 14.37%. Given CRISPR Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe CRISPR Therapeutics is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CRISPR Therapeutics	2 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.53
Teladoc Health	1 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.22

In the previous week, CRISPR Therapeutics had 4 more articles in the media than Teladoc Health. MarketBeat recorded 12 mentions for CRISPR Therapeutics and 8 mentions for Teladoc Health. CRISPR Therapeutics' average media sentiment score of 1.28 beat Teladoc Health's score of 0.89 indicating that CRISPR Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CRISPR Therapeutics	9 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teladoc Health	5 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

69.2% of CRISPR Therapeutics shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 4.3% of CRISPR Therapeutics shares are held by company insiders. Comparatively, 0.7% of Teladoc Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Teladoc Health beats CRISPR Therapeutics on 9 of the 17 factors compared between the two stocks.

How does Teladoc Health compare to Roku?

Roku (NASDAQ:ROKU) and Teladoc Health (NYSE:TDOC) are related companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

86.3% of Roku shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 13.5% of Roku shares are owned by insiders. Comparatively, 0.7% of Teladoc Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Roku has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Roku, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Roku	$4.74B	3.91	$88.36M	$1.33	94.40
Teladoc Health	$2.53B	0.47	-$200.32M	-$0.97	N/A

In the previous week, Roku had 27 more articles in the media than Teladoc Health. MarketBeat recorded 35 mentions for Roku and 8 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 0.89 beat Roku's score of 0.54 indicating that Teladoc Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Roku	14 Very Positive mention(s)	4 Positive mention(s)	14 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
Teladoc Health	5 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Roku has a beta of 2.04, suggesting that its share price is 104% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.08, suggesting that its share price is 108% more volatile than the broader market.

Roku currently has a consensus price target of $143.42, indicating a potential upside of 14.23%. Teladoc Health has a consensus price target of $7.53, indicating a potential upside of 14.37%. Given Teladoc Health's higher probable upside, analysts clearly believe Teladoc Health is more favorable than Roku.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Roku	0 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	0 Strong Buy rating(s)	2.81
Teladoc Health	1 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.22

Roku has a net margin of 4.06% compared to Teladoc Health's net margin of -6.81%. Roku's return on equity of 7.64% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Roku	4.06%	7.64%	4.61%
Teladoc Health	-6.81%	-11.45%	-5.54%

Summary

Roku beats Teladoc Health on 13 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to Zoom Communications?

Teladoc Health (NYSE:TDOC) and Zoom Communications (NASDAQ:ZM) are related companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

In the previous week, Zoom Communications had 73 more articles in the media than Teladoc Health. MarketBeat recorded 81 mentions for Zoom Communications and 8 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 0.89 beat Zoom Communications' score of 0.76 indicating that Teladoc Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	5 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Zoom Communications	27 Very Positive mention(s)	14 Positive mention(s)	24 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Zoom Communications has a net margin of 41.99% compared to Teladoc Health's net margin of -6.81%. Zoom Communications' return on equity of 12.06% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-6.81%	-11.45%	-5.54%
Zoom Communications	41.99%	12.06%	9.84%

Teladoc Health has a beta of 2.08, meaning that its share price is 108% more volatile than the broader market. Comparatively, Zoom Communications has a beta of 1, meaning that its share price has a similar volatility profile to the broader market.

Teladoc Health currently has a consensus target price of $7.53, indicating a potential upside of 14.37%. Zoom Communications has a consensus target price of $107.95, indicating a potential upside of 2.19%. Given Teladoc Health's higher possible upside, equities analysts clearly believe Teladoc Health is more favorable than Zoom Communications.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.22
Zoom Communications	0 Sell rating(s)	12 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.54

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 66.5% of Zoom Communications shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by company insiders. Comparatively, 11.5% of Zoom Communications shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Zoom Communications has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Zoom Communications, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53B	0.47	-$200.32M	-$0.97	N/A
Zoom Communications	$4.87B	6.39	$1.90B	$6.81	15.51

Summary

Zoom Communications beats Teladoc Health on 12 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to American Well?

Teladoc Health (NYSE:TDOC) and American Well (NYSE:AMWL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

American Well has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53B	0.47	-$200.32M	-$0.97	N/A
American Well	$249.32M	0.53	-$95.70M	-$5.42	N/A

Teladoc Health has a net margin of -6.81% compared to American Well's net margin of -37.02%. Teladoc Health's return on equity of -11.45% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-6.81%	-11.45%	-5.54%
American Well	-37.02%	-32.11%	-24.12%

Teladoc Health presently has a consensus price target of $7.53, indicating a potential upside of 14.37%. American Well has a consensus price target of $7.13, indicating a potential downside of 10.79%. Given Teladoc Health's stronger consensus rating and higher possible upside, research analysts clearly believe Teladoc Health is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.22
American Well	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 56.1% of American Well shares are held by institutional investors. 0.7% of Teladoc Health shares are held by company insiders. Comparatively, 11.8% of American Well shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Teladoc Health has a beta of 2.08, meaning that its stock price is 108% more volatile than the broader market. Comparatively, American Well has a beta of 1.52, meaning that its stock price is 52% more volatile than the broader market.

In the previous week, Teladoc Health had 6 more articles in the media than American Well. MarketBeat recorded 8 mentions for Teladoc Health and 2 mentions for American Well. Teladoc Health's average media sentiment score of 0.89 beat American Well's score of 0.12 indicating that Teladoc Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	5 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
American Well	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Teladoc Health beats American Well on 12 of the 16 factors compared between the two stocks.

Get Teladoc Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TDOC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TDOC vs. The Competition

Export

Metric	Teladoc Health	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$1.19B	$8.38B	$6.46B	$23.20B
Dividend Yield	N/A	2.98%	2.76%	4.10%
P/E Ratio	-6.79	21.27	21.00	30.65
Price / Sales	0.47	19.11	562.18	24.50
Price / Cash	3.65	86.20	43.49	25.12
Price / Book	0.89	5.84	10.41	4.74
Net Income	-$200.32M	$183.47M	$3.57B	$1.07B
7 Day Performance	-0.60%	64.18%	6.40%	2.36%
1 Month Performance	13.83%	49.96%	3.54%	1.58%
1 Year Performance	-3.37%	4.53%	34.14%	28.42%

Teladoc Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TDOC Teladoc Health	3.2529 of 5 stars	$6.59 +0.2%	$7.53 +14.4%	-3.4%	$1.19B	$2.53B	N/A	5,600
AMZN Amazon.com	4.7699 of 5 stars	$264.86 +0.3%	$312.67 +18.1%	+32.5%	$2.85T	$742.78B	31.68	1,576,000	Trending News
CRSP CRISPR Therapeutics	3.5804 of 5 stars	$48.56 +0.3%	$65.47 +34.8%	+36.6%	$4.68B	$3.51M	N/A	460	Positive News
ROKU Roku	3.7237 of 5 stars	$124.15 +0.1%	$143.42 +15.5%	+81.9%	$18.30B	$4.74B	93.35	3,600
ZM Zoom Communications	4.1609 of 5 stars	$98.87 -1.3%	$96.57 -2.3%	+33.2%	$29.13B	$4.87B	15.95	7,438	Earnings Report Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:TDOC) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Teladoc Health (TDOC) Competitors

TDOC vs. AMZN, CRSP, ROKU, ZM, and AMWL

How does Teladoc Health compare to Amazon.com?

Summary

How does Teladoc Health compare to CRISPR Therapeutics?

Summary

How does Teladoc Health compare to Roku?

Summary

How does Teladoc Health compare to Zoom Communications?

Summary

How does Teladoc Health compare to American Well?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TDOC vs. The Competition

Teladoc Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Teladoc Health (TDOC) Competitors

TDOC vs. AMZN, CRSP, ROKU, ZM, and AMWL

How does Teladoc Health compare to Amazon.com?

Which has stronger valuation and earnings, TDOC or AMZN?

Do analysts prefer TDOC or AMZN?

Does the media refer more to TDOC or AMZN?

Which has more risk and volatility, TDOC or AMZN?

Is TDOC or AMZN more profitable?

Do insiders & institutionals have more ownership in TDOC or AMZN?

Summary

How does Teladoc Health compare to CRISPR Therapeutics?

Is CRSP or TDOC more profitable?

Which has preferable valuation and earnings, CRSP or TDOC?

Which has more risk & volatility, CRSP or TDOC?

Do analysts prefer CRSP or TDOC?

Does the media prefer CRSP or TDOC?

Do insiders and institutionals believe in CRSP or TDOC?

Summary

How does Teladoc Health compare to Roku?

Do institutionals & insiders believe in ROKU or TDOC?

Which has stronger earnings and valuation, ROKU or TDOC?

Does the media prefer ROKU or TDOC?

Which has more risk & volatility, ROKU or TDOC?

Do analysts recommend ROKU or TDOC?

Is ROKU or TDOC more profitable?

Summary

How does Teladoc Health compare to Zoom Communications?

Does the media refer more to TDOC or ZM?

Is TDOC or ZM more profitable?

Which has more volatility & risk, TDOC or ZM?

Do analysts recommend TDOC or ZM?

Do institutionals and insiders believe in TDOC or ZM?

Which has higher earnings & valuation, TDOC or ZM?

Summary

How does Teladoc Health compare to American Well?

Which has stronger earnings & valuation, TDOC or AMWL?

Is TDOC or AMWL more profitable?

Do analysts recommend TDOC or AMWL?

Do institutionals & insiders hold more shares of TDOC or AMWL?

Which has more volatility and risk, TDOC or AMWL?

Does the media refer more to TDOC or AMWL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TDOC vs. The Competition

Teladoc Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools